Ethylene Oxide (EO) Residue Testing for Masks: Standards, Methods and Compliance

Ethylene oxide (EO) residue testing is an essential safety and quality control step for face masks and respirators that are sterilized with ethylene oxide gas, verifying that residual sterilant levels comply with strict regulatory limits. This technical article reviews the applicable standards, including GB/T 14233.1, YY 0469, GB 19083 and EN ISO 10993-7, the headspace gas chromatography methods used to quantify residues, and practical guidance for manufacturers seeking accurate, compliant test results from accredited third-party laboratories.

Technical Overview

Most single-use medical masks and respirators are built around polypropylene melt-blown nonwoven filter media, a material that is sensitive to heat and moisture. Ethylene oxide (EO, also written as EtO) sterilization is therefore widely adopted because it is effective at relatively low temperatures and penetrates breathable sterile packaging. However, EO is a reactive alkylating agent. Residual EO adsorbed in the polymer matrix can migrate out of the mask over time and expose the wearer, causing mucosal and respiratory irritation, sensitization, and genotoxic effects; EO is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC). In addition, EO can react with moisture and chloride-containing materials to form toxic by-products such as ethylene chlorohydrin (2-chloroethanol, ECH) and ethylene glycol (EG).

After sterilization, masks must undergo an aeration or degassing cycle to reduce residues to biologically acceptable levels, and analytical testing is required to demonstrate that the cycle is effective. In China, product standards such as GB 19083, YY 0469 and YY/T 0969 specify that EO residue shall not exceed 10 μg/g, determined according to GB/T 14233.1. Internationally, EN ISO 10993-7 (and its Chinese counterpart GB/T 16886.7) establishes device-based tolerable exposure limits for EO and ECH. Testing is typically performed by ISO/IEC 17025-accredited third-party laboratories using headspace gas chromatography.

Testing Samples

Medical and Surgical Masks

Disposable medical masks, surgical masks and procedure masks supplied in sterile condition are the most common EO-treated products submitted for residue testing. These products are typically evaluated against YY/T 0969, YY 0469, EN 14683 or ASTM F2100, all of which reference residual sterilant requirements when ethylene oxide sterilization is used.

Medical Protective Masks and Respirators

Medical protective masks (GB 19083), filtering half-mask respirators such as KN95 (GB 2626), N95 (NIOSH/42 CFR 84) and FFP2 (EN 149) types may also be EO-sterilized, particularly for surgical-grade variants. Whenever the sterilization process uses EO, residue testing is mandatory before the product can be released, regardless of the filtration standard the respirator meets.

Materials, Components and Packaging

Melt-blown filter media, spunbond nonwoven layers, elastic ear loops and the sterile barrier packaging can all retain EO to different degrees. Incoming material checks and packaging compatibility studies help manufacturers identify components that trap EO and extend aeration time unnecessarily.

Testing Items

The core testing program for EO-sterilized masks includes the following parameters:

• Ethylene oxide (EO) residue: the primary test item; Chinese mask standards set a maximum limit of 10 μg/g of mask material.
• Ethylene chlorohydrin (ECH) residue: a hydrolysis and chlorination by-product that is frequently quantified alongside EO, especially for ISO 10993-7 conformity assessments.
• Ethylene glycol (EG) residue: generally of lower concern for masks but may be included in a comprehensive sterilization residuals assessment.
• Device-based exposure calculation: converting concentration data (μg/g) into total residual dose per device (mg/device) for comparison with ISO 10993-7 tolerable limits.

Under EN ISO 10993-7, the indicative tolerable exposure for EO from a single device is approximately 4 mg for limited-duration contact (up to 24 hours), 2 mg for prolonged contact (24 hours to 30 days), and about 60 μg per day for long-term contact exceeding 30 days. For ECH, indicative limits are approximately 5 mg for limited and prolonged exposure and 2 mg per day for long-term exposure. For a typical face mask worn for short durations, the 10 μg/g limit in the Chinese product standards is the binding criterion, and manufacturers should always consult the current edition of the applicable standard.

Testing Methods

Sample Preparation and Extraction

Sampling must be representative of the released product, taken after the aeration or quarantine period is complete. Following GB/T 14233.1, the widely used simulated-use extraction approach involves cutting the mask into small pieces, weighing a representative portion (typically about 1 g) into a headspace vial, adding a measured volume of water, and equilibrating at 37 ± 1 °C for 1 hour to simulate the conditions of use. Alternative procedures include direct static headspace analysis of the material or exhaustive extraction when a total residual dose per device is required for ISO 10993-7 evaluation.

Headspace Gas Chromatography

Quantification is performed by static headspace gas chromatography with a flame ionization detector (HS-GC-FID). Sealed vials are heated in the headspace autosampler, typically in the range of 60–80 °C, to drive EO and ECH into the gas phase. The vapor phase is injected onto a capillary column, and compounds are identified by retention time against reference standards. Suitable columns are moderately polar phases such as 6% cyanopropylphenyl-dimethylpolysiloxane, with helium, nitrogen or hydrogen as carrier gas. Gas chromatography coupled with mass spectrometry (GC-MS) can be used for confirmation when required.

Calibration and Method Validation

Quantification is based on external calibration using certified EO standards, prepared gravimetrically in acetonitrile or supplied as certified gas mixtures, covering at least five concentration levels across the working range. A validated method should demonstrate linearity (correlation coefficient typically 0.995 or better), method detection limits well below the 10 μg/g specification, spike recoveries generally within 80–120%, and repeatability with a relative standard deviation below 5%. Each analytical batch includes reagent blanks, calibration verification standards and duplicate samples to ensure data integrity. Results are reported in μg/g, together with the expanded measurement uncertainty.

Applications

EO residue testing supports multiple points in the mask product lifecycle:

• Product registration and regulatory submissions, including NMPA registration in China, CE marking under the EU Medical Device Regulation, and FDA 510(k) submissions in the United States.
• Routine batch release testing of sterile mask lots following the sterilization and aeration cycle.
• Validation of aeration parameters (temperature, air changes, time) and determination of the minimum quarantine period before products can be shipped.
• Supplier and incoming material control to identify nonwoven fabrics or packaging films with excessive EO retention.
• Shelf-life and stability studies confirming that residues remain below limits throughout the labeled expiry period.
• Failure investigations and complaint follow-up when users report odor, irritation or suspected sterilant exposure.

FAQ

Why is ethylene oxide used to sterilize masks?

EO sterilization operates at low temperature and penetrates porous polypropylene materials and breathable packaging, making it suitable for heat- and moisture-sensitive masks. Radiation and steam alternatives are not always compatible with the filtration media or elastic components, so EO remains a common industrial choice.

What is the maximum permitted EO residue in masks?

For masks sold under Chinese standards such as GB 19083, YY 0469 and YY/T 0969, the EO residue must not exceed 10 μg/g of the mask. For international submissions, the results are also assessed against the device-based tolerable exposure limits in EN ISO 10993-7, which depend on the contact duration of the device.

When should samples be taken for testing?

Samples should be drawn after the full aeration and quarantine cycle has been completed, because EO desorbs gradually from the material. Testing immediately after sterilization without aeration will overstate the residual level that the user would actually experience.

Which analytical technique is used?

Static headspace gas chromatography with flame ionization detection is the standard technique, executed according to GB/T 14233.1 or equivalent validated laboratory methods. GC-MS confirmation is available when identification certainty or very low detection limits are required.

Is testing for ECH also necessary?

ECH testing is strongly recommended and is often requested by regulators for ISO 10993-7 conformity, because EO can react with chloride-containing materials to form this more persistent by-product. Many accredited third-party laboratories offer EO and ECH as a combined test package.

How many samples are needed and how long does testing take?

A typical submission consists of several intact masks taken randomly from one sterilization batch, from which representative portions are cut for replicate extraction and analysis. Routine analysis is generally completed within a few working days once samples are received, though timelines vary with laboratory workloads and any additional validation requested.